Abstract
Objective: Our aim was to assess the effect of the day of ovum retrieval on outcome in an IVF program scheduled for weekday-only ovum retrievals.
Design: This was a retrospective study of patients who underwent transvaginal ultrasound-guided ovum retrieval (TVUS-OR) in an IVF program from August 10, 1992, to April 30, 1993.
Setting: A university-based tertiary referral hospital center was the setting.
Participants and Methods: All patients (n=501) who underwent TVUS-OR were divided into three groups: (1) patients who underwent TVUS-OR on Monday; (2) patients who underwent retrieval on Tuesday, Wednesday, or Thursday; and (3) patients who underwent retrieval on Friday. All patients were induced by the same controlled ovarian hyperstimulation protocol, which consisted of a GnRH analogue “flare-up” followed by parenteral menotropins, after a scheduled oral contraceptive-induced menses. Patients and cycle characteristics in the three groups were compared and clinical outcome was evaluated.
Results: The similarity of patients and cycle characteristics confirmed the uniformity of the three groups. No difference was found in any of the clinical outcomes. However, in the first half of the program, we revealed a trend in which patients at high risk for ovarian hyperstimulation syndrome, requiring freezing all embryos and not allowing transfer during the treatment cycle, occurred more commonly in women whose retrieval occurred on Monday. This trend disappeared in the second half of the analysis.
Conclusions: In an in vitro fertilization program in which ovum retrievals occurred only on weekdays, no significant difference in outcome was found in patients undergoing ovum retrieval on Monday or Friday versus midweek. In addition to significant savings by eliminating weekend retrievals, IVF outcome is not compromised.
Similar content being viewed by others
References
Tempelton A, Look PV, Lumsden MA, Angel R, Aitken J, Duncan AW, Baird DT: The recovery of preovulatory oocytes using fixed schedule of ovulation induction and follicles aspiration. Br J Obstet Gynaecol 1984;91:148–154
Wardle PG, Foster PA, Mitchel JD, McLaughlin EA, Williams JAC, Corrigan E, Ray BD, McDermott A, Hull MGR: Norethisterone treatment to control timing of the IVF cycle. Hum Reprod 1986;1:455–457
Frydman R, Forman R, Rainhorn D, Belaisch-Allart J, Hazout A, Testart J: A new approach to follicular stimulation for in vitro fertilization programmed oocyte retrieval. Fertil Steril 1986;46:657–662
Patton PE, Burry KA, Wolf DP, Kiessling AA, Creamer MJ: The use of oral contraceptives to regulate oocyte retrieval. Fertil Steril 1988;49(4):716–718
Gonen Y, Jackobson W, Casper RF: Gonadotropin suppression with oral contraceptives before in-vitro fertilization. Fertil Steril 1990;53:282–287
Steptoe PC, Edwards RG, Walters DE: Observation on 767 pregnancies and 500 births after human in vitro fertilization. Hum Reprod 1986;1:89–94
Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226–230
Abdalla HI, Barber R, Leonard T, Kirkland A, Mitchell A, Power M, Owen E, Studd JWW: Timed oocyte collection in an assisted conception program using GnRH analog. Hum Reprod 1989;4:927–930
Abdalla HI, Leonard T, Barber R, Kirkland A, Stocker P, Owen E, Studd JWW: In-vitro fertilization. Br Med J 1988;296:1470
Chang SY, Lee CL, Wang ML, Hu ML, Lai YM, Chang MY, Soong YK: No detrimental effects in delaying initiation of gonadotropin administration after pituitary desensitization with gonadotropin releasing hormone agonist. Fertil Steril 1993;59(1):183–186
Dimitry ES, Oskarsson T, Conaghan J, Margara R, Winston RML: Beneficial effects of a 24 h delay in human chorionic gonadotropin administration during in-vitro fertilization treatment cycles. Hum Reprod 1991;6:944–946
Tan SL, Balen A, El Hussein E, Mills C, Campbell S, Yovich J, Jacobs HS: A prospective randomize study of the optimum timing of the human chorionic gonadotropin administration after pituitary desensitization in in-vitro fertilization. Fertil Steril 1992;57:1259–1264
Dimitry ES, Bates SA, Oskarsson T, Margara R, Winston RML: Programming in vitro fertilization for a 5- or 3-day week. Fertil Steril 1991;55:934–938
Veeck LL: Oocyte assessment and biological performance. Ann NY Acad Sci 1988;541:259–274
Schenker JG, Weinstein D: Ovarian hyperstimulation syndrome: A current survey. Fertil Steril 1978;30:255–268
Smitz J, Devroey P, Braeckmans P, Camus M, Khan I, Staessen C, Van Waesberghel L, Wisanto A, Van Steirteghem AC: Management of failed cycles in an IVF/GIFT program with a combination of a GnRH-a and hMG. Hum Reprod 1987;2:309–314
Porter RN, Smith W, Craft IL, Abdulwalid NA, Jacobs HS: Induction of ovulation for in vitro fertilization using buserelin and gonadotropins. Lancet 1984;2:1284–1285
Loumay E: The control of endogenous secretion of LH by gonadotropin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 1990;5:357–376
Rutherford AJ: Improvement of in vitro fertilization after treatment with busereline, an agonist of luteinizing hormone releasing hormone. Br Med J 1988;296:1765–1768
Zorn JR, Boyer P, Guichard A: Never on Sunday: programming for IVF-ET and GIFT. Lancet 1987;1:385–386
Golan A, Ron-El R, Herman A, Weinraub Z, Soffer Y, Caspi E: Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone releasing hormone microcapsules and menotropin for in vitro fertilization. Fertil Steril 1988;50:912–916
Amso NN, Shaw RW, Ahuja KK, Morris N: Prevention of ovarian hyperstimulation syndrome. Fertil Steril 1991;55:220
Amso NN, Ahuja KK, Morris N, Shaw RW: The management of predicted ovarian hyperstimulation involving gonadotropin releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil Steril 1990;53:1087–1090
Horne G, Ibrahim ZH, Matson PL, Buck P, Lieberman BA: Management of ovarian hyperstimulation following ovulation induction with buserelin and human menopausal gonadotropin. J Obstet Gynecol 1990;10:330–332
Wada I, Matson PL, Troup SA, Morrol DR, Hunt L, Lieberman BA: Does elective cryopreservation of all embryos from woman at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition? Br J Obstet Gynaecol 1993;100:265–269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ben-Chetrit, A., Senoz, S. & Greenblatt, E.M. In vitro fertilization programmed for weekday-only oocyte harvest: Analysis of outcome based on actual retrieval day. J Assist Reprod Genet 14, 26–31 (1997). https://doi.org/10.1007/BF02765748
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02765748